Eric Adler
2023
In 2023, Eric Adler earned a total compensation of $3M as Chief Medical Officer and Head of Research at Lexeo Therapeutics.
Compensation breakdown
| Bonus | $234,750 |
|---|---|
| Non-Equity Incentive Plan | $80,750 |
| Option Awards | $2,419,424 |
| Salary | $296,500 |
| Other | $11,400 |
| Total | $3,042,824 |
Adler received $2.4M in option awards, accounting for 80% of the total pay in 2023.
Adler also received $234.8K in bonus, $80.8K in non-equity incentive plan, $296.5K in salary and $11.4K in other compensation.
Rankings
In 2023, Eric Adler's compensation ranked 296th out of 2,978 executives tracked by ExecPay. In other words, Adler earned more than 90.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 296 out of 2,978 | 90th |
Division Manufacturing | 162 out of 1,637 | 90th |
Major group Chemicals And Allied Products | 108 out of 906 | 88th |
Industry group Drugs | 105 out of 869 | 88th |
Industry Biological Products, Except Diagnostic Substances | 38 out of 211 | 82nd |
Source: SEC filing on April 26, 2024.
Adler's colleagues
We found three more compensation records of executives who worked with Eric Adler at Lexeo Therapeutics in 2023.